| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2015-09-08 16:52:03 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm holds Second Quarter 2015 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its second quarter 2015 investor conference webinar scheduled on September 8, 2015 at 16:00 (EETWebinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš informs about AS “Olainfarm” latest activities and analyze the non-audited financial results of the second quarter 2015. The enclosed presentation will be presented during the webinar.
What is
webinar? How to join the
webinar? To join the webinar, we invite you to register via ej.uz/OLF_2Q2015. You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia. Information
prepared by: |
| Pielikumi |